2020 APSC共识建议:高危慢性冠脉综合征的抗栓治疗

2021-06-18 Eur Cardiol.2021 Jun 18;16:e26.

2021年6月,亚太心脏病学会(APSC)发布了高危慢性冠脉综合征的抗栓治疗共识建议,本文主要总结了当前关于高危慢性冠脉综合征的抗栓治疗的证据,并提供指导建议,以帮助临床医生管理相应的患者。

中文标题:

2020 APSC共识建议:高危慢性冠脉综合征的抗栓治疗

英文标题:

2020 Asian Pacific Society of Cardiology Consensus Recommendations on Antithrombotic Management for High-risk Chronic Coronary Syndrome

发布机构:

发布日期:

2021-06-18

简要介绍:

2021年6月,亚太心脏病学会(APSC)发布了高危慢性冠脉综合征的抗栓治疗共识建议,本文主要总结了当前关于高危慢性冠脉综合征的抗栓治疗的证据,并提供指导建议,以帮助临床医生管理相应的患者。

 

相关资料下载:
[AttachmentFileName(sort=1, fileName=2020 APSC共识建议:高危慢性冠脉综合征的抗栓治疗.pdf)] GetToolGuiderByIdResponse(projectId=1, id=f4f391c00213e6c5, title=2020 APSC共识建议:高危慢性冠脉综合征的抗栓治疗, enTitle=2020 Asian Pacific Society of Cardiology Consensus Recommendations on Antithrombotic Management for High-risk Chronic Coronary Syndrome, guiderFrom=Eur Cardiol.2021 Jun 18;16:e26., authorId=0, author=, summary=2021年6月,亚太心脏病学会(APSC)发布了高危慢性冠脉综合征的抗栓治疗共识建议,本文主要总结了当前关于高危慢性冠脉综合征的抗栓治疗的证据,并提供指导建议,以帮助临床医生管理相应的患者。, cover=https://img.medsci.cn/2021726/1627231028863_2020535.jpg, journalId=0, articlesId=null, associationId=0, associationName=, associationIntro=, copyright=0, guiderPublishedTime=Fri Jun 18 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>2021年6月,亚太心脏病学会(APSC)发布了高危慢性冠脉综合征的抗栓治疗共识建议,本文主要总结了当前关于高危慢性冠脉综合征的抗栓治疗的证据,并提供指导建议,以帮助临床医生管理相应的患者。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=95682, tagName=慢性冠脉综合征)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=43, categoryName=冠心病, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=95682, guiderKeyword=慢性冠脉综合征, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=4, opened=0, paymentType=, paymentAmount=2, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=9722, appHits=136, showAppHits=0, pcHits=452, showPcHits=9585, likes=1, shares=9, comments=10, approvalStatus=1, publishedTime=Mon Jul 26 00:50:28 CST 2021, publishedTimeString=2021-06-18, pcVisible=1, appVisible=1, editorId=1614372, editor=MedSciZeng, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=qiushida2, createdTime=Mon Jul 26 00:37:16 CST 2021, updatedBy=1614372, updatedName=MedSciZeng, updatedTime=Mon Jan 01 22:18:57 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2020 APSC共识建议:高危慢性冠脉综合征的抗栓治疗.pdf)])
2020 APSC共识建议:高危慢性冠脉综合征的抗栓治疗.pdf
下载请点击:
评论区 (9)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1179657, encodeId=234711e9657fa, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44174789483, createdName=1521809481, createdTime=Sat Jan 01 22:48:49 CST 2022, time=2022-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057569, encodeId=9e77105e56947, content=不错 谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Mon Oct 04 14:25:21 CST 2021, time=2021-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007477, encodeId=c4e2100e4775f, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210813/beecb740bfb247b5af86be0c6c721d46/a4de252e6a65478f9b7851366a5a10a9.jpg, createdBy=72024184433, createdName=拼搏的老马, createdTime=Fri Aug 13 06:53:34 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005801, encodeId=1bd31005801f7, content=想看看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84815566568, createdName=茕医者, createdTime=Sat Aug 07 12:44:44 CST 2021, time=2021-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005140, encodeId=0f29100514059, content=支持, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210804/27e6f4b113bf423999f739fd1a178fec/4f3f724952494d329b544c8e9ada67ed.jpg, createdBy=c9352514268, createdName=冰豪, createdTime=Wed Aug 04 16:09:51 CST 2021, time=2021-08-04, status=1, ipAttribution=)]
    2022-01-01 1521809481

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1179657, encodeId=234711e9657fa, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44174789483, createdName=1521809481, createdTime=Sat Jan 01 22:48:49 CST 2022, time=2022-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057569, encodeId=9e77105e56947, content=不错 谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Mon Oct 04 14:25:21 CST 2021, time=2021-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007477, encodeId=c4e2100e4775f, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210813/beecb740bfb247b5af86be0c6c721d46/a4de252e6a65478f9b7851366a5a10a9.jpg, createdBy=72024184433, createdName=拼搏的老马, createdTime=Fri Aug 13 06:53:34 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005801, encodeId=1bd31005801f7, content=想看看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84815566568, createdName=茕医者, createdTime=Sat Aug 07 12:44:44 CST 2021, time=2021-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005140, encodeId=0f29100514059, content=支持, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210804/27e6f4b113bf423999f739fd1a178fec/4f3f724952494d329b544c8e9ada67ed.jpg, createdBy=c9352514268, createdName=冰豪, createdTime=Wed Aug 04 16:09:51 CST 2021, time=2021-08-04, status=1, ipAttribution=)]
    2021-10-04 H8888888

    不错 谢谢分享

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1179657, encodeId=234711e9657fa, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44174789483, createdName=1521809481, createdTime=Sat Jan 01 22:48:49 CST 2022, time=2022-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057569, encodeId=9e77105e56947, content=不错 谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Mon Oct 04 14:25:21 CST 2021, time=2021-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007477, encodeId=c4e2100e4775f, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210813/beecb740bfb247b5af86be0c6c721d46/a4de252e6a65478f9b7851366a5a10a9.jpg, createdBy=72024184433, createdName=拼搏的老马, createdTime=Fri Aug 13 06:53:34 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005801, encodeId=1bd31005801f7, content=想看看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84815566568, createdName=茕医者, createdTime=Sat Aug 07 12:44:44 CST 2021, time=2021-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005140, encodeId=0f29100514059, content=支持, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210804/27e6f4b113bf423999f739fd1a178fec/4f3f724952494d329b544c8e9ada67ed.jpg, createdBy=c9352514268, createdName=冰豪, createdTime=Wed Aug 04 16:09:51 CST 2021, time=2021-08-04, status=1, ipAttribution=)]
    2021-08-13 拼搏的老马

    很好

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1179657, encodeId=234711e9657fa, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44174789483, createdName=1521809481, createdTime=Sat Jan 01 22:48:49 CST 2022, time=2022-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057569, encodeId=9e77105e56947, content=不错 谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Mon Oct 04 14:25:21 CST 2021, time=2021-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007477, encodeId=c4e2100e4775f, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210813/beecb740bfb247b5af86be0c6c721d46/a4de252e6a65478f9b7851366a5a10a9.jpg, createdBy=72024184433, createdName=拼搏的老马, createdTime=Fri Aug 13 06:53:34 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005801, encodeId=1bd31005801f7, content=想看看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84815566568, createdName=茕医者, createdTime=Sat Aug 07 12:44:44 CST 2021, time=2021-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005140, encodeId=0f29100514059, content=支持, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210804/27e6f4b113bf423999f739fd1a178fec/4f3f724952494d329b544c8e9ada67ed.jpg, createdBy=c9352514268, createdName=冰豪, createdTime=Wed Aug 04 16:09:51 CST 2021, time=2021-08-04, status=1, ipAttribution=)]
    2021-08-07 茕医者

    想看看

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1179657, encodeId=234711e9657fa, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44174789483, createdName=1521809481, createdTime=Sat Jan 01 22:48:49 CST 2022, time=2022-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057569, encodeId=9e77105e56947, content=不错 谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Mon Oct 04 14:25:21 CST 2021, time=2021-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007477, encodeId=c4e2100e4775f, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210813/beecb740bfb247b5af86be0c6c721d46/a4de252e6a65478f9b7851366a5a10a9.jpg, createdBy=72024184433, createdName=拼搏的老马, createdTime=Fri Aug 13 06:53:34 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005801, encodeId=1bd31005801f7, content=想看看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84815566568, createdName=茕医者, createdTime=Sat Aug 07 12:44:44 CST 2021, time=2021-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005140, encodeId=0f29100514059, content=支持, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210804/27e6f4b113bf423999f739fd1a178fec/4f3f724952494d329b544c8e9ada67ed.jpg, createdBy=c9352514268, createdName=冰豪, createdTime=Wed Aug 04 16:09:51 CST 2021, time=2021-08-04, status=1, ipAttribution=)]
    2021-08-04 冰豪

    支持

    0